Barrington Research Analysts Lower Earnings Estimates for U.S. Physical Therapy, Inc. (NYSE:USPH)

U.S. Physical Therapy, Inc. (NYSE:USPH) – Equities research analysts at Barrington Research reduced their FY2024 earnings per share estimates for shares of U.S. Physical Therapy in a report issued on Wednesday, October 9th. Barrington Research analyst M. Petusky now forecasts that the company will post earnings of $2.20 per share for the year, down from their previous estimate of $2.30. Barrington Research currently has a “Outperform” rating and a $108.00 price target on the stock. The consensus estimate for U.S. Physical Therapy’s current full-year earnings is $2.51 per share. Barrington Research also issued estimates for U.S. Physical Therapy’s Q4 2024 earnings at $0.56 EPS, Q1 2025 earnings at $0.43 EPS, Q2 2025 earnings at $0.77 EPS, Q3 2025 earnings at $0.61 EPS and Q4 2025 earnings at $0.69 EPS.

U.S. Physical Therapy (NYSE:USPH) last issued its quarterly earnings data on Tuesday, August 13th. The company reported $0.73 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.82 by ($0.09). The company had revenue of $167.19 million for the quarter, compared to the consensus estimate of $163.34 million. U.S. Physical Therapy had a return on equity of 8.18% and a net margin of 4.06%. The firm’s revenue was up 10.4% on a year-over-year basis. During the same period in the prior year, the company earned $0.76 EPS.

USPH has been the subject of a number of other research reports. Bank of America reaffirmed a “neutral” rating and set a $90.00 price target (down previously from $114.00) on shares of U.S. Physical Therapy in a research report on Monday. StockNews.com upgraded shares of U.S. Physical Therapy from a “sell” rating to a “hold” rating in a report on Wednesday, August 21st.

U.S. Physical Therapy Stock Performance

Shares of U.S. Physical Therapy stock opened at $77.52 on Thursday. The company has a debt-to-equity ratio of 0.28, a current ratio of 1.88 and a quick ratio of 1.88. The firm has a market cap of $1.17 billion, a price-to-earnings ratio of 63.02, a price-to-earnings-growth ratio of 3.97 and a beta of 1.39. The stock’s 50-day moving average is $84.38 and its 200-day moving average is $94.61. U.S. Physical Therapy has a one year low of $76.18 and a one year high of $113.63.

Institutional Investors Weigh In On U.S. Physical Therapy

Large investors have recently added to or reduced their stakes in the business. Canada Pension Plan Investment Board bought a new position in U.S. Physical Therapy in the 2nd quarter valued at about $28,000. Innealta Capital LLC bought a new position in shares of U.S. Physical Therapy during the second quarter worth approximately $30,000. Quest Partners LLC increased its stake in shares of U.S. Physical Therapy by 2,808.3% during the second quarter. Quest Partners LLC now owns 349 shares of the company’s stock worth $32,000 after purchasing an additional 337 shares during the period. Northwest Bank & Trust Co bought a new position in shares of U.S. Physical Therapy during the fourth quarter worth approximately $37,000. Finally, Quarry LP lifted its holdings in U.S. Physical Therapy by 1,291.9% during the 2nd quarter. Quarry LP now owns 515 shares of the company’s stock worth $48,000 after purchasing an additional 478 shares during the last quarter.

Insider Buying and Selling at U.S. Physical Therapy

In other news, Director Kathleen A. Gilmartin bought 2,000 shares of the stock in a transaction that occurred on Tuesday, September 3rd. The shares were acquired at an average cost of $86.09 per share, for a total transaction of $172,180.00. Following the completion of the acquisition, the director now owns 18,904 shares in the company, valued at approximately $1,627,445.36. This represents a 0.00 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other U.S. Physical Therapy news, COO Graham D. Reeve sold 1,724 shares of the company’s stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $82.50, for a total value of $142,230.00. Following the sale, the chief operating officer now owns 7,038 shares in the company, valued at $580,635. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Kathleen A. Gilmartin acquired 2,000 shares of the business’s stock in a transaction dated Tuesday, September 3rd. The stock was acquired at an average cost of $86.09 per share, with a total value of $172,180.00. Following the completion of the transaction, the director now owns 18,904 shares of the company’s stock, valued at approximately $1,627,445.36. The trade was a 0.00 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Corporate insiders own 1.70% of the company’s stock.

U.S. Physical Therapy Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, September 13th. Shareholders of record on Friday, August 23rd were paid a $0.44 dividend. The ex-dividend date was Friday, August 23rd. This represents a $1.76 dividend on an annualized basis and a yield of 2.27%. U.S. Physical Therapy’s dividend payout ratio is 143.09%.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.